Yogendra Narayanrao Keche*

Department of Pharmacology, All India Institute of Medical Sciences, Raipur, India

*Corresponding Author: Yogendra Narayanrao Keche, Department of Pharmacology, All India Institute of Medical Sciences, Raipur, India.

Received: October 25, 2022 Published: November 01, 2022

Elderly is the person above 65 years of age. Elderly Suffer from or having chances of Alzheimer's disease, Parkinson's disease, vascular dementia, stroke, visual impairment, cataracts and macular degeneration, atherosclerosis, coronary heart disease, heart failure, diabetes, arthritis, osteoporosis, and fractures, cancer, incontinence. Hence, they need a greater number of drugs for the treatment. There are changes in responses to some drugs with advanced age and also the drug usage patterns changed due increase in number of drugs. Many diseases, nutritional problems and reduced financial resources lead to reduced dosing compliance in elderly [1].

References

1. Katzung BG. “Special Aspects of Geriatric Pharmacology”. In Basic and Clinical Pharmacology 2018; Katzung BG Editor, 14^th Edition, Mc Graw Hill Education (India) Private Limited, Chennai (2018): 1058-1067.
2. Cockcroft DW and Gault MH. “Prediction of creatinine clearance from serum creatinine”. Nephron 16 (1976): 31-41.
3. Friedman JR., et al. “Correlation of estimated renal function parameters versus 24-hour creatinine clearance in ambulatory elderly”. Journal of the American Geriatrics Society 37 (1989): 145-149.
4. MacLennan WJ., et al. “Protein intake and serum albumin levels in the elderly”. Gerontology 23 (1977): 360-367.
5. Greenblatt DJ., et al. “Importance of protein binding for the interpretation of serum or plasma drug concentrations”. Journal of Clinical Pharmacology 22 (1982): 259-263.
6. Conti MC., et al. “Serum albumin level and physical disability as predictors of mortality in older persons”. JAMA 272 (1994): 1036-1042.
7. Mooney H., et al. “Alterations in the liver with aging”. Clinical Gastroenterology 14 (1985): 757-771.
8. Vestal RE., et al. “Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking”. Clinical Pharmacology and Therapeutics 18 (1975): 425-432.
9. O’Malley K., et al. “Determinants of anticoagulant control in patients receiving warfarin”. British Journal of Clinical Pharmacology 4 (1977): 309-314.
10. Shephard AMM., et al. “Age as a determinant of sensitivity to warfarin”. British Journal of Clinical Pharmacology 4 (1977): 315-320.
11. Gurwitz JH., et al. “Aging and the anticoagulant response to warfarin”. Annals of Internal Medicine 116 (1992): 901-904.
12. Gallagher P., et al. “STOPP (Screening Tool of Older Persons’ Prescriptions)/START (Screening Tool to Alert Doctors to Right Treatment) criteria for potentially inappropriate prescribing in older people: version 2”. Age and Ageing (2014): 1-6.
13. Leipzig RM. “Geriatric Pharmacology and Drug Prescribing for Older Adults”. In: Soriano, R.P., Fernandez, H.M., Cassel, C.K., Leipzig, R.M. (eds) Fundamentals of Geriatric Medicine. Springer, New York, NY (2007).

Citation

Citation: Yogendra Narayanrao Keche. “Geriatric Pharmacology: What to Consider While Prescribing to an Elderly Person?". Acta Scientific Pharmacology 3.12 (2022): 01-03.

Copyright

Copyright: © 2022 Yogendra Narayanrao Keche. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.